[
  {
    "date": "2023-12-30",
    "symbol": "CELZ",
    "period": "FY",
    "entityregistrantname": "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.",
    "entitycentralindexkey": 1187953,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2023-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "000-53500",
    "entityincorporationstatecountrycode": "NV",
    "entitytaxidentificationnumber": "87-0622284",
    "entityaddressaddressline1": "211 E Osborn Road",
    "entityaddresscityortown": "Phoenix",
    "entityaddressstateorprovince": "AZ",
    "entityaddresspostalzipcode": 85012,
    "cityareacode": 480,
    "icfrauditorattestationflag": "false",
    "auditorname": "Haynie & Company",
    "auditorlocation": "Salt Lake City, Utah",
    "auditorfirmid": 457,
    "localphonenumber": "399-2822",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "CELZ",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "cash": 3466867,
    "investments": 6520191,
    "inventorynet": 6594,
    "prepaidexpenseandotherassetscurrent": 277246,
    "assetscurrent": 10270898,
    "otherassets": 3281,
    "finitelivedintangibleassetsnet": 441011,
    "assets": 10715190,
    "accountspayablecurrent": 317280,
    "accruedliabilitiescurrent": 39920,
    "duetorelatedpartycurrent": 14194,
    "liabilitiescurrent": 371394,
    "liabilities": 371394,
    "commonstockvalue": 1431,
    "additionalpaidincapital": 69711749,
    "retainedearningsaccumulateddeficit": -59098432,
    "treasurystockvalue": 270952,
    "stockholdersequity": 10343796,
    "liabilitiesandstockholdersequity": 10715190,
    "commonstocknoparvalue": 0.001,
    "commonstocksharesauthorized": 5000000,
    "commonstocksharesissued": 1431126,
    "commonstocksharesoutstanding": 1373626,
    "treasurystockcommonshares": 57500,
    "revenues": 9000,
    "costofrevenue": 3600,
    "grossprofit": 5400,
    "researchanddevelopmentexpense": 1970639,
    "sellinggeneralandadministrativeexpense": 3560309,
    "amortizationofintangibleassets": 94584,
    "operatingexpenses": 5625532,
    "operatingincomeloss": -5620132,
    "interestandotherincome": 333558,
    "nonoperatingincomeexpense": 333558,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -5286574,
    "netincomeloss": -5286574,
    "earningspersharesbasicanddiluted": -3.76,
    "weightedaveragenumberofshareoutstandingbasic": 1407632,
    "sharesissued": 1431126,
    "stockbasedcompensation": 36648,
    "roundupsharesissuedinreversestocksplitshares": 23502,
    "roundupsharesissuedinreversestocksplitamount": 24,
    "purchaseofcommonstock": -270952,
    "sharebasedcompensation": 36648,
    "unrealizedgainlossoninvestments": 34087,
    "increasedecreaseininventories": -3600,
    "increasedecreaseinothercurrentassets": -108202,
    "increasedecreaseinaccountspayable": -2950258,
    "netcashprovidedbyusedinoperatingactivities": -8027885,
    "paymentstoacquireinvestments": 22854815,
    "proceedsfromsaleofequitymethodinvestments": 26400000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 100000,
    "netcashprovidedbyusedininvestingactivities": 3445185,
    "paymentsforrepurchaseofcommonstock": 270952,
    "netcashprovidedbyusedinfinancingactivities": -270952,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -4853652,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 3466867,
    "timedepositsatorabovefdicinsurancelimit": 250000,
    "deferredrevenue": 40000,
    "interestincomeother": 34000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11183,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 102085,
    "finitelivedintangibleassetsamortizationexpenserollingyeartwo": 101774,
    "finitelivedintangibleassetsamortizationexpenserollingyearthree": 64650,
    "finitelivedintangibleassetsamortizationexpenserollingyearfour": 40000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 35000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 97502,
    "futureamortizationcost": 441011,
    "licensingagreements": 860000,
    "adjustmentforamortization": 9972,
    "additionofnewassets": 100000,
    "accumulatedamortizationoflicensingagreements": -418989,
    "accumulatedamortization": -94584,
    "capitalleaseobligationscurrent": 300000,
    "workerscompensationdiscountpercent": 0.25,
    "companypaid": 50000,
    "amortizationexpenses": 48440,
    "subordinatedborrowinginterestrate": 0.05,
    "otherintangibleassetsnet": 21042,
    "warrantexercisepriceincrease": 0.0037,
    "expirationperiodoffinitelivedintangibleassets": "May 19, 2027",
    "expectedamountofamortization": 1172,
    "depreciationandamortization": 56000,
    "paymentsintheeventofcommercializationoftechnology": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 11183,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 7735,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 83.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 210.83,
    "weightedaverageliferemainingoutstandingbeginning": "P8Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P8Y1M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9295,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y6M",
    "shareprice": 16.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P10Y",
    "allocatedsharebasedcompensationexpense": 40132,
    "sharesheldinemployeestockoptionplansuspenseshares": 16984,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 60000,
    "debtinstrumentinterestrateduringperiod": 0.0081,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.9295,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 2284932,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P4Y10M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P3Y2M19D",
    "dilutivesecurities": 2000000,
    "stockrepurchasedduringperiodvalue": 270952,
    "warrantspurchasesharesofcommonstock": 57500,
    "prefundedwarrantsexerciseprice": 0.0001,
    "commonwarrantsexerciseprice": 20,
    "paidplacementagentfee": 1360000,
    "issuedwarranttopurchasesharesofcommonstock": 113334,
    "classofwarrantorrightoutstanding": 2284932,
    "otherresearchanddevelopmentexpense": 5000000,
    "federalincometaxexpensebenefitcontinuingoperations": 1082622,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 300783,
    "valuationallowancedeferredtaxassetchangeinamount": 1383405,
    "deferredtaxassetsoperatinglosscarryforwards": 6266742,
    "deferredtaxassetsvaluationallowance": 6266742,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057,
    "effectiveincometaxratereconciliationotheradjustments": -0.004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 1,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrates": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": 23500000
  },
  {
    "date": "2022-12-30",
    "symbol": "CELZ",
    "period": "FY",
    "entityregistrantname": "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.",
    "entitycentralindexkey": 1187953,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2022",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "000-53500",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "87-0622284",
    "icfrauditorattestationflag": "false",
    "entityaddressaddressline1": "211 E Osborn Road",
    "entityaddresscityortown": "Phoenix",
    "entityaddressstateorprovince": "AZ",
    "entityaddresspostalzipcode": 85012,
    "cityareacode": 480,
    "localphonenumber": "399-2822",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "CELZ",
    "securityexchangename": "NASDAQ",
    "auditorname": "Haynie & Company",
    "auditorlocation": "Salt Lake City, Utah",
    "auditorfirmid": 457,
    "cash": "null",
    "certificatesofdepositatcarryingvalue": "null",
    "inventorynet": 10194,
    "prepaidexpenseandotherassetscurrent": 338120,
    "assetscurrent": "null",
    "otherassets": 3281,
    "finitelivedintangibleassetsnet": 435595,
    "assets": "null",
    "accountspayablecurrent": "null",
    "accruedliabilitiescurrent": 39920,
    "duetorelatedpartiescurrent": 14194,
    "liabilitiescurrent": "null",
    "liabilities": "null",
    "commonstockvalue": 14077,
    "additionalpaidincapital": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "commonstocknoparvalue": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenues": 88600,
    "costofrevenue": 28491,
    "grossprofit": 60109,
    "researchanddevelopmentexpense": "null",
    "sellinggeneralandadministrativeexpense": "null",
    "amortizationofintangibleassets": 25000,
    "operatingexpenses": "null",
    "operatingincomeloss": "-null",
    "otherincome": 100328,
    "nonoperatingincomeexpense": 100328,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": "-null",
    "netincomeloss": "-null",
    "earningspersharebasic": -0.93,
    "earningspersharediluted": -0.93,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesissued": "null",
    "commonstockissuedforrelatedpartymanagementandpatentliabilitiesshares": 181818,
    "commonstockissuedforrelatedpartymanagementandpatentliabilitiesamount": 250000,
    "proceedsfromissuanceofcommonstock": "null",
    "stockbasedcompensation": 68746,
    "issuanceofcommonstockandaccompanyingwarrantsnetofissuancecostsshares": "null",
    "issuanceofcommonstockandaccompanyingwarrantsnetofissuancecostsamount": "null",
    "commonstockissuedforwarrantexerciseshares": "null",
    "commonstockissuedforwarrantexerciseamount": 457,
    "profitloss": "-null",
    "sharebasedcompensation": 68746,
    "increasedecreaseinaccountsreceivable": -2485,
    "increasedecreaseininventories": -672,
    "increasedecreaseinothercurrentassets": 338120,
    "increasedecreaseinaccountspayable": "null",
    "increasedecreaseinaccruedliabilities": 15535,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "paymentstoacquirerestrictedcertificatesofdeposit": "null",
    "netcashprovidedbyusedininvestingactivities": "-null",
    "proceedsfromwarrantexercises": 457,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": "-null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": "null",
    "conversionofmanagementfeesandpatentliabilityintocommonstock": 250000,
    "timedepositsatorabovefdicinsurancelimit": 250000,
    "deferredrevenue": 40000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 92085,
    "finitelivedintangibleassetsamortizationexpenserollingyeartwo": 92085,
    "finitelivedintangibleassetsamortizationexpenserollingyearthree": 91774,
    "finitelivedintangibleassetsamortizationexpenserollingyearfour": 54650,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 30000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 75002,
    "totalfutureamortizationcost": 435595,
    "licensingagreementsendingbalance": 760000,
    "accumulatedamortization": -92084,
    "accumulatedamortizationendingbalance": -324405,
    "obligationoftheinitialpayment": 300000,
    "commonstockissue": 133,
    "companypaid": 50000,
    "continuingroyaltydescription": "Within thirty (30) days of the end of each calendar quarter during the term of this Agreement, Licensee will pay Licensor five percent (5%) of the Net Income of ImmCelz™. during such calendar quarter (the “Continuing Royalty”)",
    "otherintangibleassetsnet": 200000,
    "expirationperiodoffinitelivedintangibleassets": 2026,
    "expectedannualamortizationamount": 46000,
    "expectedamountofamortization": 10000,
    "purchasesharesofcommonstock": 20189,
    "initialexercisepricepershare": 14.175,
    "fairvalueofbridgeloan": "null",
    "placementagentfee": 312750,
    "additiopnaldiscountvalueofbridgenotes": 252000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 111824,
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 111817,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 55915,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.66,
    "weightedaverageexercisepriceissued": 1.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 2.58,
    "weightedaverageliferemainingoutstandingbeginning": 4.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 9.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y1M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0113,
    "shareprice": 1.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9309000000000001,
    "allocatedsharebasedcompensationexpense": 104164,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.9295,
    "debtinstrumentinterestrateduringperiod": 0.008100000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P4Y10M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 4.22,
    "classofwarrantterm": "P5Y",
    "prefundedwarrantsexerciseprice": 0.0001,
    "commonwarrantsexerciseprice": 2,
    "paidplacementagentfee": "null",
    "issuedwarranttopurchasesharesofcommonstock": "null",
    "classofwarrantorrightoutstanding": "null",
    "federalincometaxexpensebenefitcontinuingoperations": "null",
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 582461,
    "valuationallowancedeferredtaxassetchangeinamount": "null",
    "deferredtaxassetsoperatinglosscarryforwards": "null",
    "deferredtaxassetsvaluationallowance": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057,
    "effectiveincometaxratereconciliationotheradjustments": -0.003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.264,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrates": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": 18000000,
    "valuationallowance": 1
  },
  {
    "date": "2021-12-30",
    "symbol": "CELZ",
    "period": "FY",
    "entityregistrantname": "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.",
    "entitycentralindexkey": 1187953,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2021",
    "entityfilercategory": "Non-accelerated filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "000-53500",
    "entitytaxidentificationnumber": "87-0622284",
    "entityincorporationstatecountrycode": "Nevada",
    "entityaddressaddressline1": "211 E Osborn Road",
    "entityaddresscityortown": "Phoenix",
    "entityaddressstateorprovince": "AZ",
    "entityaddresspostalzipcode": 85012,
    "cityareacode": 480,
    "localphonenumber": "399-2822",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "CELZ",
    "securityexchangename": "NASDAQ",
    "auditorname": "Haynie & Company",
    "auditorlocation": "Salt Lake City, Utah",
    "auditorfirmid": 457,
    "cashandcashequivalentsatcarryingvalue": "null",
    "accountsreceivablenet": 2485,
    "inventorynet": 10866,
    "assetscurrent": "null",
    "otherassets": 3281,
    "finitelivedintangibleassetsnet": 527679,
    "assets": "null",
    "accountspayablecurrent": 761862,
    "accruedliabilitiescurrent": 24385,
    "managementfeepayable": 250000,
    "duetorelatedpartiescurrent": 14194,
    "liabilitiescurrent": "null",
    "commonstockvalue": 6339,
    "additionalpaidincapital": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "commonstocknoparvalue": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "preferredstocknoparvalue": 0.001,
    "preferredstocksharesauthorized": 500,
    "revenues": 87754,
    "costofrevenue": 47949,
    "grossprofit": 39805,
    "researchanddevelopmentexpense": 109180,
    "sellinggeneralandadministrativeexpense": "null",
    "amortizationofintangibleassets": 25000,
    "operatingexpenses": "null",
    "operatingincomeloss": "-null",
    "interestexpense": "null",
    "gainonextinguishmentofconvertiblenotes": 585601,
    "changeinfairvalueofderivativesliabilities": "null",
    "nonoperatingincomeexpense": "null",
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": "null",
    "netincomeloss": "null",
    "earningspersharebasic": 7.37,
    "earningspersharediluted": 5.61,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofsharesoutstandingdiluted": "null",
    "sharesissued": "null",
    "stockissuedduringperiodsharesother": 89286,
    "commonstockissuedforrelatedpartymanagementandpatentliabilitiesamount": 50000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 789727,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": "null",
    "dividendssharebasedcompensation": 595380,
    "derivativegainonderivative": "null",
    "stockissuedduringperiodsharesreversestocksplits": 5621,
    "stockissuedduringperiodvaluereversestocksplits": -6,
    "proceedsfromsalesofpreferredstockshares": 4286,
    "proceedsfromlinesofcredit": 462000,
    "proceedsfromsalesofcommonstocknetofissuancecostsshares": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": "null",
    "offeringcosts": -105180,
    "dividendsonpreferredstock": -27725,
    "stockissuedduringperiodsharesstockoptionsexercised": 37870,
    "cashlessexerciseofwarrantsamount": -38,
    "warrantsissuedwithnotespayable": "null",
    "preferredstockredemptionshares": -150,
    "preferredstockredemptionsamount": -769026,
    "adjustmentofwarrantsgrantedforservices": -989346,
    "profitloss": "null",
    "amortizationofdebtdiscountpremium": 443905,
    "increasedecreaseinderivativeliabilities": "null",
    "debtinstrumentincreaseaccruedinterest": 93821,
    "gainslossesonextinguishmentofdebt": 585601,
    "increasedecreaseinaccountsreceivable": -2485,
    "increasedecreaseininventories": -10866,
    "increasedecreaseinaccountspayable": 410963,
    "increasedecreaseinaccruedliabilities": 20635,
    "increasedecreaseinpayablestocustomers": 168782,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "proceedsfromconvertibledebt": 435040,
    "paymentsonnotespayable": "-null",
    "paymentsofdebtissuancecosts": 443239,
    "paymentsofstockissuancecosts": 3281,
    "proceedsfromconvertiblenotespayable": 435040,
    "proceedsfromissuanceofpreferredstock": 462000,
    "proceedsfromissuanceofcommonstock": "null",
    "paymentofofferingcosts": -105180,
    "preferredstockredemptionpremium": 196751,
    "proceedsfromrelatedpartydebt": 223394,
    "increasedecreaseinduetootherrelatedparties": -220000,
    "repaymentsofconvertibledebt": 705405,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": "null",
    "interestpaidnet": 9186,
    "accrueddividendsonpreferredstock": 27725,
    "warrantsissuedwithnotespayableandasaservicefee": "null",
    "conversionofnotespayableaccruedinterestandderivativeliabilitiesintocommonstock": "null",
    "debtconversionconvertedinstrumentconversionofmanagementfeesandpatentliability": 50000,
    "discountsonconvertiblenotespayableduetoderivativeliabilities": 134640,
    "exchangeofpreferredstockfornotespayable": 572275,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 989346,
    "additionofnewconversionoptionderivatives": "null",
    "extinguishmentmodification": -727344,
    "conversionofnotederivatives": "-null",
    "unrealizedgainlossonderivatives": "-null",
    "extinguishmentofdebtamount": 346,
    "incrementalcommonsharesattributabletocalloptionsandwarrants": 643562,
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "netincomelossavailabletocommonstockholdersbasic": "null",
    "subtractdeemeddividendonwarrantreset": -989346,
    "netincomelossavailabletocommonstockholdersdiluted": "null",
    "dilutedearningspershareproforma": 5.61,
    "interestonnonconvertiblenotes": 1151,
    "timedepositsatorabovefdicinsurancelimit": 250000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "finitelivedintangibleassetsamortizationexpenserollingyeartwo": 92085,
    "finitelivedintangibleassetsamortizationexpenserollingyearthree": 92085,
    "finitelivedintangibleassetsamortizationexpenserollingyearfour": 92085,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 91084,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 60388,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 100000,
    "totalfutureamortizationcost": 527677,
    "licensingagreementsendingbalance": 760000,
    "accumulatedamortization": -92084,
    "accumulatedamortizationendingbalance": -232321,
    "licensefees": 250000,
    "obligationoftheinitialpayment": 300000,
    "continuingroyaltydescription": "Within thirty (30) days of the end of each calendar quarter during the term of this Agreement, Licensee will pay Licensor five percent (5%) of the Net Income of ImmCelz™",
    "otherintangibleassetsnet": 225000,
    "expirationperiodoffinitelivedintangibleassets": 2030,
    "expectedannualamortizationamount": 25000,
    "expectedamountofamortization": 10000,
    "paymentstoacquireintangibleassets": 300000,
    "debtconversionsharesissued": 789727,
    "debtconversionoriginaldebtamount1": "null",
    "debtconversionconverrtedinstrumentsharesissued": 37870,
    "commonstockissuedforcashlesswarrantexerciseshares": 43167,
    "amortizationtointerestexpense": "null",
    "termofwarrant": "five-year",
    "purchasesharesofcommonstock": 20189,
    "initialexercisepricepershare": 14.175,
    "fairvalueofbridgeloan": "null",
    "debtconversionconvertedinstrumentrate": 0.71,
    "convertiblenotespayable": 498800,
    "interestrate": 0.08,
    "debtinstrumentconvertiblethresholdtradingdays": 15,
    "placementagentfee": 312750,
    "additiopnaldiscountvalueofbridgenotes": 252000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 13125,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 4.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 4.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0113,
    "shareprice": 17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9309000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 35670,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 3.5,
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 23262,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The options vest at a rate of 1.4 on each anniversary date of the respective grants",
    "initialderivativeliabilities": "null",
    "fairvalueassumptionexpectedterms": 1,
    "convertibledebtcurrent": 697602,
    "sharesprice": 40.3,
    "derivativeliabilitymeasurementinputpercentage": 0.001,
    "derivativeliabilitymeasurementinputratios": 12.4,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.9881000000000001,
    "debtinstrumentinterestrateduringperiod": 0.0023,
    "shorttermdebtinterestrateincrease": 0.0126,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 43167,
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": 69475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsother": 932104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P2Y5M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 4.85,
    "purchaseofwarrantsshares": "null",
    "warrantexerciseprice": 4.13,
    "classofwarrantorrightoutstanding": "null",
    "classofwarrantorrightconvertedintocommonshares": 43167,
    "sharesissueduponexerciseofwarrantsshares": 30000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 15,
    "federalincometaxexpensebenefitcontinuingoperations": 325596,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 9460,
    "valuationallowancedeferredtaxassetchangeinamount": 416056,
    "deferredtaxassetsoperatinglosscarryforwards": "null",
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 67086,
    "deferredtaxassetsvaluationallowance": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.002,
    "effectiveincometaxratereconciliationotheradjustments": -0.23800000000000002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.022000000000000002,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrates": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": 8300000.000000001,
    "valuationallowance": 1,
    "productliabilitycontingencyaccrualpresentvalue": 707116
  },
  {
    "date": "2020-12-30",
    "symbol": "CELZ",
    "period": "FY",
    "entityregistrantname": "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.",
    "entitycentralindexkey": 1187953,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2020-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entityextransitionperiod": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "cashandcashequivalentsatcarryingvalue": 98012,
    "assetscurrent": 98012,
    "finitelivedintangibleassetsnet": 50960,
    "assets": 717775,
    "accountspayablecurrent": 350899,
    "accruedliabilitiescurrent": 159771,
    "managementfeepayable": 468782,
    "convertiblenotespayablecurrent": 788701,
    "duetorelatedpartiescurrent": 10800,
    "derivativeliabilitiescurrent": 38741832,
    "liabilitiescurrent": 40520785,
    "liabilities": 40520785,
    "preferredstockvalue": 3000,
    "commonstockvalue": 768536,
    "additionalpaidincapital": 21315690,
    "retainedearningsaccumulateddeficit": -61890236,
    "stockholdersequity": -61890236,
    "liabilitiesandstockholdersequity": 717775,
    "debtinstrumentunamortizeddiscountcurrent": 409649,
    "commonstocknoparvalue": 0.001,
    "commonstocksharesauthorized": 6000000000,
    "commonstocksharesissued": 768540617,
    "commonstocksharesoutstanding": 768536617,
    "preferredstocknoparvalue": 0.001,
    "preferredstocksharesauthorized": 3000000,
    "preferredstocksharesissued": 3000000,
    "preferredstocksharesoutstanding": 3000000,
    "revenues": 164500,
    "costofrevenue": 50596,
    "grossprofit": 113904,
    "sellinggeneralandadministrativeexpense": 1161947,
    "amortizationofintangibleassets": 1172,
    "operatingexpenses": 1228739,
    "operatingincomeloss": -1114835,
    "interestexpense": 1229590,
    "derivativegainlossonderivativenet": 33980805,
    "nonoperatingincomeexpense": -35210395,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -36325230,
    "netincomeloss": -36325230,
    "earningspersharebasicanddiluted": -0.13,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 289730374,
    "sharebasedcompensation": 170323,
    "amortizationofdebtdiscountpremium": 979960,
    "changeinfairvalueofderivativesliabilities": 33980805,
    "increasedecreaseinaccountsreceivable": 5600,
    "increasedecreaseinaccountspayable": 30114,
    "increasedecreaseinaccruedliabilities": 167029,
    "increasedecreaseinpayablestocustomers": 490051,
    "netcashprovidedbyusedinoperatingactivities": -434556,
    "netcashprovidedbyusedininvestingactivities": -250000,
    "paymentsonconvertiblenotespayable": 17000,
    "proceedsfromconvertibledebt": 710920,
    "netcashprovidedbyusedinfinancingactivities": 693920,
    "cashandcashequivalentsperiodincreasedecrease": 9364,
    "interestpaidnet": 6000,
    "adjustmentstoadditionalpaidincapitalconvertibledebtwithconversionfeature": 101351,
    "conversionofnotespayableaccruedinterestandderivativeliabilitiesintocommonstock": 4162045,
    "debtconversionconvertedinstrumentconversionofmanagementfeesandpatentliability": 160000,
    "sharesissued": 768536617,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 681731395,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 1366705,
    "stockissuedduringperiodsharesother": 64314883,
    "stockissuedduringperiodvalueother": 160000,
    "derivativegainonderivative": 2795340,
    "dividendssharebasedcompensation": 170323,
    "stockissuedduringperiodsharesreversestocksplits": 1293,
    "stockissuedduringperiodvaluereversestocksplits": -1,
    "derivativeliabilities": 1397997,
    "additionofnewconversionoptionderivatives": 2572723,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 2795340,
    "unrealizedgainlossonderivatives": 1209175,
    "workingcapitaldeficit": 40422773,
    "deferredrevenue": 32000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 93327,
    "finitelivedintangibleassetsamortizationexpenserollingyeartwo": 93327,
    "finitelivedintangibleassetsamortizationexpenserollingyearthree": 93327,
    "finitelivedintangibleassetsamortizationexpenserollingyearfour": 93327,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 93327,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 152835,
    "totalfutureamortizationcost": 619470,
    "additionofnewassets": 250000,
    "licensingagreementsendingbalance": 760000,
    "accumulatedamortization": -66792,
    "accumulatedamortizationendingbalance": -140237,
    "continuingroyaltydescription": "Within thirty (30) days of the end of each calendar quarter during the term of this Agreement, Licensee will pay Licensor five percent (5%) of the Net Income of ImmCelz. during such calendar quarter (the &#8220;Continuing Royalty&#8221;)",
    "finitelivedintangibleassetusefullife": "P10Y",
    "expirationperiodoffinitelivedintangibleassets": 2025,
    "finitelivedpatentsgross": 250000,
    "expectedamountofamortization": 9972,
    "debtconversionconvertedinstrumentsharesissued1": 14000000000,
    "duetorelatedpartiescurrentandnoncurrent": 18782,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1305005,
    "interestexpenseotherlongtermdebt": 828710,
    "unamortizeddiscountsonacceptancesexecuted": 409650,
    "numberofsharesissueduponconversionofdebt": 681731395,
    "debtconversionamount": 1366705,
    "debtinstrumentfaceamount": 831140,
    "debtinstrumentinterestrateduringperiod": 0.08,
    "debtconversiondescription": "The notes are convertible into shares of the Company&#8217;s common stock at conversion prices ranging from 60% to 71% of the average of the two lowest traded prices of the Company&#8217;s common stock during the previous 15 trading days preceding the conversion date, the lowest trade price during the previous 15 trading days.",
    "debtinstrumentconvertibleconversionpercentage": 0.71,
    "initialderivativeliabilities": 2572723,
    "convertibledebtcurrent": 1864233,
    "derivativeliabilitiesnoncurrent": 38741832,
    "sharesprice": 0.0365,
    "derivativeliabilitymeasurementinputpercentage": 0.0016,
    "derivativeliabilitymeasurementinputratio": 0.0278,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 76372446,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.0057,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 0.0057,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P5Y7M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P2Y5M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0011,
    "shareprice": 0.004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9924,
    "allocatedsharebasedcompensationexpense": 102081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 35670,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 0.0029,
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 11630953,
    "warrantdescriptions": "outstanding warrants were increased from the initial issuance of 145,717 warrants to 34,531,666 to reflect the terms of the warrant agreement.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The options vest at a rate of 50,000 on each anniversary date of the respective grants. ",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 76372446,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 41630953,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsother": 29697233,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P3Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y5M19D",
    "classofwarrantorrightoutstanding": 76372446,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 8214286,
    "sharesissueduponexerciseofwarrantsshares": 30000000,
    "classofwarrantorrightwarrantterm": "P3Y",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.0029,
    "federalincometaxexpensebenefitcontinuingoperations": 250771,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": 69671,
    "valuationallowancedeferredtaxassetchangeinamount": 320442,
    "deferredtaxassetsoperatinglosscarryforwards": 1593282,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 155063,
    "deferredtaxassetsvaluationallowance": -1748345,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.089,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.002,
    "effectiveincometaxratereconciliationotheradjustments": -0.202,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.009,
    "auctionmarketpreferredsecuritiesstockseriesparvaluepershare": 1200,
    "debtinstrumentconvertibleconversionprice1": 0.05
  },
  {
    "date": "2019-12-30",
    "symbol": "CELZ",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.",
    "entitycentralindexkey": 1187953,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "tradingsymbol": "CELZ",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entitypublicfloat": 4632440,
    "entityinteractivedatacurrent": "Yes",
    "cash": 88648,
    "accountsreceivablenetcurrent": 5600,
    "assetscurrent": 94248,
    "finitelivedintangibleassetsnet": 6428,
    "assets": 530803,
    "accountspayablecurrent": 320785,
    "accruedliabilitiescurrent": 120492,
    "managementfeeandpatentliabilityrelatedpartytransaction": 240082,
    "convertiblenotespayablecurrent": 1062266,
    "duetorelatedpartiescurrent": 10800,
    "derivativeliabilitiescurrent": 6847877,
    "liabilitiescurrent": 8602302,
    "liabilities": 8602302,
    "preferredstockvalue": 3000,
    "commonstockvalue": 22489,
    "additionalpaidincapitalcommonstock": 17468018,
    "retainedearningsaccumulateddeficit": -25565006,
    "stockholdersequity": -25565006,
    "liabilitiesandstockholdersequity": 530803,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 3000000,
    "preferredstocksharesissued": 3000000,
    "preferredstocksharesoutstanding": 3000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 6000000000,
    "commonstocksharesissued": 22493046,
    "commonstocksharesoutstanding": 22489046,
    "debtinstrumentunamortizeddiscountcurrent": 560899,
    "revenues": 165500,
    "costofrevenue": 45499,
    "grossprofit": 120001,
    "sellinggeneralandadministrativeexpense": 1223219,
    "amortizationofintangibleassets": 1172,
    "operatingexpenses": 1250169,
    "operatingincomeloss": -1130168,
    "interestexpense": 1895528,
    "gainslossesonextinguishmentofdebt": -366042,
    "fairvalueadjustmentofwarrants": 5091935,
    "nonoperatingincomeexpense": -7353505,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -8483673,
    "netincomeloss": -8483673,
    "earningspersharebasicanddiluted": -0.82,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 10343162,
    "amortizationofdebtdiscountpremium": 1723451,
    "liabilitiesfairvalueadjustment": -5091935,
    "lossonextinguishmentofconvertiblenotespayable": -266042,
    "excessconsiderationissuedinconnectionwithrelieveofmanagementfeesandpatentliability": 100000,
    "increasedecreaseinaccountsreceivable": -4000,
    "increasedecreaseinaccountspayable": -11054,
    "increasedecreaseinaccruedliabilities": 189256,
    "increasedecreaseinotheroperatingliabilities": -120000,
    "netcashprovidedbyusedinoperatingactivities": -1213093,
    "repaymentsofrelatedpartydebt": 50000,
    "proceedsfromnotespayable": 50000,
    "repaymentsofconvertibledebt": 263411,
    "prepaymentpremiumpaidonconvertibledebt": 41699,
    "proceedsfromconvertibledebt": 1302795,
    "netcashprovidedbyusedinfinancingactivities": 997685,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -215408,
    "cashandcashequivalentsatcarryingvalue": 88648,
    "interestpaidnet": 18177,
    "relatedpartyliabilityincurredforadditionalpatentcosts": 300000,
    "debtconversionconvertedinstrumentamount1": 4156811,
    "debtconversionconvertedinstrumentconversionofmanagementfeesandpatentliability": 138000,
    "sharesoutstanding": 3000000,
    "stockissuedduringperiodtorelatedpartyvaluenewissues": 4067,
    "stockissuedduringperiodtorelatedpartysharesnewissues": 4066667,
    "stockissuedduringperiodvaluestockoptionsexercised": 531,
    "stockissuedduringperiodsharesstockoptionsexercised": 531247,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 11873,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 11873057,
    "adjustmentstoadditionalpaidincapitalother": 2655536,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 188822,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitypurchases": 87012,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysales": 39849,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 910308,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": -191587,
    "deferredrevenue": 30000,
    "workingcapitaldeficit": 8508054,
    "cashfdicinsuredamount": 250000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5044260,
    "classofwarrantorrightoutstanding": 5044260,
    "finitelivedintangibleassetexpirationperiod": 2026,
    "finitelivedintangibleassetsexpectedannualamortization": 1172,
    "paymentstoacquireintangibleassets": 200000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 67211,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 67211,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 67211,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 67211,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 67211,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 100500,
    "debtconversionconvertedinstrumentsharesissued1": 176000000,
    "duetorelatedpartiescurrentandnoncurrent": 82,
    "longtermpurchasecommitmentamount": 50000,
    "stockissuedduringperiodsharespatentagreement": 66667,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1623165,
    "prepaymentpremiumsassociatedwithextinguishment": 41699,
    "extinguishmentofdebtamount": 313111,
    "debtinstrumentfaceamount": 1572400,
    "debtinstrumentinterestrateduringperiod": 0.02,
    "debtinstrumentconvertibleconversionratio1": 60,
    "debtinstrumentunamortizeddiscount": 374124,
    "debtinstrumentconvertiblethresholdtradingdays": 2,
    "debtinstrumentconvertiblethresholdconsecutivetradingdays1": 15,
    "amortizationoffinancingcosts": 1613226,
    "numberofsharescancelleduponconversionofconvertiblenotetopromissorynote": 21533,
    "originalissuediscount": 11943.57,
    "derivativeliabilities": 6847877,
    "shareprice": 0.59,
    "derivativegainlossonderivativenet": -3512648,
    "derivativeliabilitymeasurementinput": 1.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8525,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0156,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 26.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 26.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y7M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y7M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The options vest at a rate of 333 on each anniversary date of the respective grants.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 5044260,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 242864,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 594051,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsother": 4549975,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsforfeitures": 101695,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingvestedandexpectedtovest": 5044260,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingvestedandexpectedtovestweightedaverageexerciseprice": 0.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P3Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P3Y29D",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 531247,
    "stockissuedduringperiodshareswarrantsissued": 242841,
    "increasednumberofwarrantsissued": 4549975,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.59,
    "classofwarrantorrightconvertedintocommonshares": 594051,
    "federalincometaxexpensebenefitcontinuingoperations": -272800,
    "stateandlocalincometaxexpensebenefitcontinuingoperations": -75792,
    "valuationallowancedeferredtaxassetchangeinamount": -348592,
    "deferredtaxassetsoperatinglosscarryforwards": 1347378,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 80525,
    "deferredtaxassetsvaluationallowance": 1427903,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.009,
    "effectiveincometaxratereconciliationotheradjustments": -0.179,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.04,
    "operatinglosscarryforwards": 5300000,
    "deferredincometaxprovisionpercent": 0.357
  }
]